Only if it it Permetrex related I would think. Everything else is down the track but as we know, the dermatitis track is quite short for us holders. The phase 2 USA acne is a lot longer and if ever the twain should meet, another classic phrase will ensue. Should BOT do some sort of Permetrex deal in the future, my personal thoughts are that it by itself could be worth 6cents a share easy with future royalties. Easy.
Add to My Watchlist
What is My Watchlist?
